The selective TrkB agonist 7,8-dihydroxyflavone has been found to benefit motor symptoms and survival of the N171-82Q mouse model of HD (493) but studies of this compound as a therapeutic for cognitive deficits, depressive behavior or HPA-axis pathology have yet to be conducted. The gene discussed is NTRK2; the disease is Huntington disease.